UNSPSC 51203604: Oxycinchophen

This classification denotes a uricosuric agent and nonnarcotic analgesic with the molecular formula C16H11NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) UK6392GD5W, chemically known as 4-quinolinecarboxylic acid, 3-hydroxy-2-phenyl- (9ci) but more generally known as oxycinchophen, which bears US NIH Compound Identifier 10239. European Medicines Agency schedules Oxycinchophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09559MIG.

UNSPSC 51203604 Oxycinchophen (Commodity) shows limited recent state and local procurement activity directly aligned with the code's nominal pharmaceutical scope. The recent opportunities posted under this code encompass broader medical supply procurement—naloxone and drug deactivation systems, medical and first aid supplies for emergency response, and generic pharmaceuticals distributed through cooperative purchasing vehicles—rather than oxycinchophen specifically. State and local issuing bodies soliciting under or near this code include county health departments, city fire rescue divisions, state health commissions, and multistate cooperative purchasing alliances. The work itself ranges from emergency response consumables (naloxone kits, bandaging, airway devices, cardiac monitoring equipment) to pharmaceutical manufacturer direct-contracting arrangements and generic drug supply agreements.

Activity spans Florida, Texas, Minnesota, and Oregon, with representation from Seminole County (health initiatives), the City of Tampa Fire Department (emergency medical supplies), the Texas Health and Human Services Commission (pharmacy benefit program development), and the Minnesota Multistate Cooperative Purchasing Alliance (multistate pharmaceutical distribution). Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 drug deactivation systems annually (response deadline July 26, 2026, delivered quarterly to Sanford, Florida); the City of Tampa's IFB for 169 line items of medical and first aid supplies for its Fire Department Rescue Division, estimated at $700,000.00, with a 5% bid discount for certified Small Local Business Enterprises (response deadline March 13, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic pharmaceuticals and OTC products, with proposals due March 26, 2026, and contract effective date of July 1, 2026. The Texas Health and Human Services Commission issued an exploratory RFI in April 2026 to gather vendor capabilities for direct-to-manufacturer prescription programs, indicating early-stage procurement planning rather than immediate opportunity.